| Breakdown | TTM | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 104.50M | 95.40M | 91.20M | 84.20M | 88.50M | 102.40M |
| Gross Profit | 63.50M | 62.10M | 57.20M | 52.10M | 62.10M | 73.00M |
| EBITDA | 24.30M | -288.50M | 31.30M | 16.20M | 39.60M | 47.00M |
| Net Income | 145.20M | -307.80M | -163.90M | 167.20M | -201.90M | 51.80M |
Balance Sheet | ||||||
| Total Assets | 3.23B | 2.48B | 2.51B | 2.78B | 2.56B | 2.75B |
| Cash, Cash Equivalents and Short-Term Investments | 23.10M | 22.90M | 19.40M | 16.70M | 11.10M | 94.90M |
| Total Debt | 1.09B | 815.50M | 527.20M | 589.70M | 533.20M | 489.80M |
| Total Liabilities | 1.19B | 895.00M | 588.20M | 662.40M | 588.30M | 550.20M |
| Stockholders Equity | 2.04B | 1.58B | 1.92B | 2.11B | 1.97B | 2.20B |
Cash Flow | ||||||
| Free Cash Flow | -14.90M | -7.70M | 5.60M | 15.90M | 24.50M | 43.10M |
| Operating Cash Flow | -14.30M | -7.60M | 5.80M | 16.20M | 24.90M | 43.20M |
| Investing Cash Flow | -396.00M | -231.70M | 105.10M | -31.40M | -118.30M | -72.90M |
| Financing Cash Flow | 191.60M | 242.80M | -108.20M | 6.30M | 9.60M | -14.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £3.49B | 3.98 | 7.75% | 5.85% | -20.83% | ― | |
69 Neutral | £2.50B | 7.76 | 8.78% | 2.58% | -0.04% | 655.16% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | £1.16B | 5.45 | 7.18% | 2.52% | 12.73% | ― | |
63 Neutral | £1.72B | 12.12 | 4.48% | 3.93% | 2.30% | ― | |
57 Neutral | £658.48M | -2.68 | -5.24% | 7.31% | -1.67% | -120.18% | |
50 Neutral | £223.62M | 35.14 | 5.91% | 2.71% | -14.09% | ― |